Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Price:
1 055.8 INR
1.03%
Market Closed
Updated:
Jun 9, 2024
Zydus Lifesciences Ltd
Net Income (Common)
|
Zydus Lifesciences Ltd
Net Income (Common) Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Net Income (Common)
₹38.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Net Income (Common)
₹55.8B
|
CAGR 3-Years
42%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Net Income (Common)
₹41.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
11%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Net Income (Common)
₹89.1B
|
CAGR 3-Years
55%
|
CAGR 5-Years
21%
|
CAGR 10-Years
13%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Net Income (Common)
₹15B
|
CAGR 3-Years
7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Net Income (Common)
₹19.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Zydus Lifesciences Ltd's Net Income (Common)?
Net Income (Common)
38.6B
INR
38.6B
INR
Based on the financial report for Mar 31, 2024, Zydus Lifesciences Ltd's Net Income (Common) amounts to 38.6B INR.
What is Zydus Lifesciences Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
17%
17%
Over the last year, the Net Income (Common) growth was 97%. The average annual Net Income (Common) growth rates for Zydus Lifesciences Ltd have been 22% over the past three years , 16% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
